Select a Cancer Type:
Leukemia
Advancing CML Management Towards an Ideal Patient Journey
Opinion
Video
The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following:
- What are the biggest unmet needs you see for CML patients today, and how do you think emerging therapies and research could address those gaps in the future?
- What excites you most about the potential advancements in CML management that may be on the horizon in the next 5-10 years?
- How do you envision the CML patient experience being transformed compared to today?
Recent Videos
Related Content
What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?September 16th 2022
New Treatments Lend a Positive Outlook to Patients With GVHDFebruary 28th 2022
View additional resources on CureToday.com
Advertisement
Advertisement
